Lydia (for Salveen Richter)

Analyst

Goldman Sachs

Equibles does not estimate personal net worth.

About Lydia (for Salveen Richter)

Lydia (for Salveen Richter) is recorded as Analyst at Goldman Sachs. Lydia (for Salveen Richter) has spoken on 3 earnings calls across 2 companies, most recently for Agios Pharmaceuticals, Inc. on July 30, 2026. Those appearances were for Agios Pharmaceuticals, Inc. (AGIO) and uniQure N.V. (QURE). The companies whose calls Lydia (for Salveen Richter) spoke on are classified in the Healthcare sector.

Lydia (for Salveen Richter) on recent calls

“Could you just speak broadly to the current breakout between transfusion and non-transfusion dependent patients and when you anticipate the non-transfusion population to make up a majority of patients on treatment.”

Analyst — Goldman Sachs, Agios Pharmaceuticals, Inc. Q2 FY2026 Earnings Call · July 30, 2026

“Just on the regulatory side, again, if you could provide any more kind of color on the ongoing discussions, particularly around the standard of care control arm, and how that might impact recruitment and retention in the study, given the somewhat open-label nature of that.”

Analyst — Goldman Sachs, uniQure N.V. Q2 FY2026 Earnings Call · July 29, 2026

“Is there any additional color you can provide on the split between the non-transfusion and transfusion-dependent patients amongst these 44 scripts that have been written?”

Analyst — Goldman Sachs, Agios Pharmaceuticals, Inc. Q4 FY2025 Earnings Call · February 12, 2026